deucravacitinib
bms,pfizer,galapagos,roivant sciences
['psoriasis', 'deucra', 'deucrava', '$pfe', '$glpg', '$bmy', '$roiv']
pdufa for deucravacitinib (tyk2) in moderate to severe psoriasis is tomorrow - label will be interesting to watch for this moa $bmy $glpg $pfe $roiv